Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Bernice a. Marcopulos, Thomas M. Guterbock & Emily F. Matusz. (2020) Survey research in neuropsychology: A systematic review. The Clinical Neuropsychologist 34:1, pages 32-55.
Read now
Read now
Giorgia Cosano, Manuela Giangreco, Silvia Ussai, Tullio Giorgini, Emanuele Biasutti, Fabio Barbone & Federica Edith Pisa$suffix/text()$suffix/text(). (2016) Polypharmacy and the use of medications in inpatients with acquired brain injury during post-acute rehabilitation: A cross-sectional study. Brain Injury 30:3, pages 353-362.
Read now
Read now
Molly McNett, Wendy Sarver & Patricia Wilczewski. (2012) The prevalence, treatment and outcomes of agitation among patients with brain injury admitted to acute care units. Brain Injury 26:9, pages 1155-1162.
Read now
Read now
Baseer Yasseen, Angela Colantonio & Graham Ratcliff. (2008) Prescription medication use in persons many years following traumatic brain injury. Brain Injury 22:10, pages 752-757.
Read now
Read now
Articles from other publishers (37)
Gabrielle CatafordLaurie-Anne MontonStephanie KarzonCamille Livernoche-LeducMar Saavedra-MitjansMarie-Julie PotvinFrancis BernardLisa BurryCaroline ArbourDavid R. Williamson. (2024) Cognitive and Motor Function Effects of Antipsychotics in Traumatic Brain Injury: A Systematic Review of Pre-Clinical Studies. Neurotrauma Reports 5:1, pages 181-193.
Crossref
Crossref
Inder D. Kalra & Thomas K. Watanabe. (2023) Enhancing management of agitation after traumatic brain injury: Psychiatric perspectives and quantitative assessments. NeuroRehabilitation 53:2, pages 177-185.
Crossref
Crossref
Mohammad SHIMIA, Arad IRANMEHR, Amir VALIZADEH, Farhad MIRZAEI, Mohamad NAMVAR, Ebrahim RAFIEI, Ahsan RAHIMI, Aida KHADIVI & Kamkar AEINFAR. (2023) A placebo-controlled randomized clinical trial of amantadine hydrochloride for evaluating the functional improvement of patients following severe acute traumatic brain injury. Journal of Neurosurgical Sciences 67:5.
Crossref
Crossref
Sarah L. Carrier, Jennie Ponsford, Ruby K. Phyland, Amelia J. Hicks & Adam McKay. (2022) Effectiveness of Non-Pharmacological Interventions for Agitation during Post-Traumatic Amnesia following Traumatic Brain Injury: A Systematic Review. Neuropsychology Review 33:2, pages 374-392.
Crossref
Crossref
William Torregrossa, Loredana Raciti, Carmela Rifici, Giuseppina Rizzo, Gianfranco Raciti, Carmela Casella, Antonino Naro & Rocco Salvatore Calabrò. (2023) Behavioral and Psychiatric Symptoms in Patients with Severe Traumatic Brain Injury: A Comprehensive Overview. Biomedicines 11:5, pages 1449.
Crossref
Crossref
Grace Song, Mira Koro, Leon Berzen, Anthony Tung, Andrew Ryan & Joseph Chun Wearn Tham. (2023) Pharmacological Treatment of Disinhibition in Acquired Brain Injury. Journal of Clinical Psychopharmacology 43:2, pages 161-166.
Crossref
Crossref
Elham Rahmani, Tricia Lemelle, Hunter Sharp, Ehsan Smarbafzadeh & Anita Kablinger. (2022) A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury in a Southwest Virginia inpatient population. Journal of Clinical Pharmacy and Therapeutics 47:12, pages 2083-2090.
Crossref
Crossref
Joshua A. Vova. (2021) A narrative review of pharmacologic approaches to symptom management of pediatric patients diagnosed with anti-NMDA receptor encephalitis. Journal of Pediatric Rehabilitation Medicine 14:3, pages 333-343.
Crossref
Crossref
Elham Rahmani, Tricia M. Lemelle, Ehsan Samarbafzadeh & Anita S. Kablinger. (2021) Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews. Journal of Head Trauma Rehabilitation 36:4, pages E262-E283.
Crossref
Crossref
Adam McKay, Jessica Trevena-Peters & Jennie Ponsford. (2021) The Use of Atypical Antipsychotics for Managing Agitation After Traumatic Brain Injury. Journal of Head Trauma Rehabilitation 36:3, pages 149-155.
Crossref
Crossref
Amelia J. Hicks, Fiona J. Clay, Malcolm Hopwood, Amelia C. James, Luke A. Perry, Mahesh Jayaram, Rachel Batty & Jennie L. Ponsford. (2021) Efficacy and Harms of Pharmacological Interventions for Anxiety after Traumatic Brain Injury: Systematic Review. Journal of Neurotrauma 38:5, pages 519-528.
Crossref
Crossref
Ruby K Phyland, Adam McKay, John Olver, Mark Walterfang, Malcolm Hopwood, Amelia J Hicks, Duncan Mortimer & Jennie L Ponsford. (2020) Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial. Trials 21:1.
Crossref
Crossref
Roy F. Kohnen, Jan C.M. Lavrijsen, Reinier P. Akkermans, Debby L. Gerritsen & Raymond T.C.M. Koopmans. (2020) The Prevalence and Determinants of Neuropsychiatric Symptoms in People With Acquired Brain Injury in Nursing Homes. Journal of the American Medical Directors Association 21:11, pages 1643-1650.
Crossref
Crossref
Theodore A. Henderson, Muriel J. van Lierop, Mary McLean, John Michael Uszler, John F. Thornton, Yin-Hui Siow, Dan G. Pavel, Joe Cardaci & Phil Cohen. (2020) Functional Neuroimaging in Psychiatry—Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know. Frontiers in Psychiatry 11.
Crossref
Crossref
Roy Kohnen, Jan Lavrijsen, Odile Smals, Debby Gerritsen & Raymond Koopmans. (2019) Prevalence and characteristics of neuropsychiatric symptoms, quality of life and psychotropics in people with acquired brain injury in long‐term care. Journal of Advanced Nursing 75:12, pages 3715-3725.
Crossref
Crossref
Amelia J. Hicks, Fiona J. Clay, Malcolm Hopwood, Amelia C. James, Mahesh Jayaram, Luke A. Perry, Rachel Batty & Jennie L. Ponsford. (2019) The Efficacy and Harms of Pharmacological Interventions for Aggression After Traumatic Brain Injury—Systematic Review. Frontiers in Neurology 10.
Crossref
Crossref
Rebekah MannixRoger ZemekKeith Owen YeatesKristy ArbogastShireen AtabakiMohammed BadawyMiriam H. BeauchampDarcy BeerSteven BinBrett BursteinWilliam CraigDan CorwinQuynh DoanMichael EllisStephen B. FreedmanIsabelle GagnonJocelyn GravelJohn LeddyAngela Lumba-BrownChristina MasterAndrew R. MayerGrace ParkMichelle PenqueTara RhineKelly RussellKathryn SchneiderMichael BellStephen Wisniewski. (2019) Practice Patterns in Pharmacological and Non-Pharmacological Therapies for Children with Mild Traumatic Brain Injury: A Survey of 15 Canadian and United States Centers. Journal of Neurotrauma 36:20, pages 2886-2894.
Crossref
Crossref
Tiphaine Bourseau, Virginie Saoût, Pauline Ali, Uriell Pouliquen-Loriferne, Philippe Allain & Mickaël Dinomais. (2019) A Cross-Sectional Study of Treatments for Behavioral Disorders Following Traumatic Brain Injury: Comparison With French Recommendations. Journal of Head Trauma Rehabilitation 34:4, pages E51-E60.
Crossref
Crossref
Karameh Kuemmerle & William P. MeehanIIIIII. (2019) Treatment of Pediatric Concussion. Seminars in Pediatric Neurology 30, pages 60-67.
Crossref
Crossref
Amelia J. HicksFiona J. ClayMalcolm HopwoodAmelia C. JamesMahesh JayaramRachel BattyLuke A. PerryJennie L. Ponsford. (2018) Efficacy and Harms of Pharmacological Interventions for Neurobehavioral Symptoms in Post-Traumatic Amnesia after Traumatic Brain Injury: A Systematic Review. Journal of Neurotrauma 35:23, pages 2755-2775.
Crossref
Crossref
Flora M. HammondMark ShererJames F. MalecRoss D. ZafonteSureyya DikmenJennifer BognerKathleen R. BellJason BarberNancy Temkin. (2018) Amantadine Did Not Positively Impact Cognition in Chronic Traumatic Brain Injury: A Multi-Site, Randomized, Controlled Trial. Journal of Neurotrauma 35:19, pages 2298-2305.
Crossref
Crossref
Ilyas Sagar-Ouriaghli, Kate Lievesley & Paramala J Santosh. (2018) Propranolol for treating emotional, behavioural, autonomic dysregulation in children and adolescents with autism spectrum disorders. Journal of Psychopharmacology 32:6, pages 641-653.
Crossref
Crossref
Sungchul Huh, Tae Wan Kim, Jung Hyun Yang, Myung Hoon Moon, Soo-Yeon Kim & Hyun-Yoon Ko. (2018) Pharmacotherapy Prescription Trends for Cognitive-Behavioral Disorder in Patients With Brain Injury in Korea. Annals of Rehabilitation Medicine 42:1, pages 35.
Crossref
Crossref
Inder D. Kalra & Thomas K. Watanabe. (2017) Mood Stabilizers for Traumatic Brain Injury-Related Agitation. Journal of Head Trauma Rehabilitation 32:6, pages E61-E64.
Crossref
Crossref
David R. Williamson, Anne Julie Frenette, Lisa Burry, Marc M. Perreault, Emmanuel Charbonney, François Lamontagne, Marie-Julie Potvin, Jean-François Giguère, Sangeeta Mehta & Francis Bernard. (2016) Pharmacological interventions for agitation in patients with traumatic brain injury: protocol for a systematic review and meta-analysis. Systematic Reviews 5:1.
Crossref
Crossref
Jacques Luauté, David Plantier, Laurent Wiart & Laurence Tell. (2016) Care management of the agitation or aggressiveness crisis in patients with TBI. Systematic review of the literature and practice recommendations. Annals of Physical and Rehabilitation Medicine 59:1, pages 58-67.
Crossref
Crossref
D. Plantier & J. Luauté. (2016) Drugs for behavior disorders after traumatic brain injury: Systematic review and expert consensus leading to French recommendations for good practice. Annals of Physical and Rehabilitation Medicine 59:1, pages 42-57.
Crossref
Crossref
Suzanne Bock, Rod Grim, Todd F. Barron, Andrew Wagenheim, Yaowen Eliot Hu, Matthew Hendell, John Deitch & Ellen Deibert. (2015) Factors associated with delayed recovery in athletes with concussion treated at a pediatric neurology concussion clinic. Child's Nervous System 31:11, pages 2111-2116.
Crossref
Crossref
Flora M. Hammond, Ryan S. Barrett, Timothy Shea, Ronald T. Seel, Thomas W. McAlister, Darryl Kaelin, David K. Ryser, John D. Corrigan, Nora Cullen & Susan D. Horn. (2015) Psychotropic Medication Use During Inpatient Rehabilitation for Traumatic Brain Injury. Archives of Physical Medicine and Rehabilitation 96:8, pages S256-S273.e14.
Crossref
Crossref
Karen A Kinnaman, Rebekah C Mannix, R Dawn Comstock & William P MeehanIIIIII. (2013) Management strategies and medication use for treating paediatric patients with concussions. Acta Paediatrica 102:9.
Crossref
Crossref
Andrew I. Geller, Wilawan Nopkhun, Marly N. Dows‐Martinez & Dale C. Strasser. (2012) Polypharmacy and the Role of Physical Medicine and Rehabilitation. PM&R 4:3, pages 198-219.
Crossref
Crossref
Anne Julie FrenetteSalmaan KanjiLaura ReesDavid R. WilliamsonMarc M. PerreaultAlexis F. TurgeonFrancis BernardDean A. Fergusson. (2012) Efficacy and Safety of Dopamine Agonists in Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials. Journal of Neurotrauma 29:1, pages 1-18.
Crossref
Crossref
Michael J. Noetzel. 2012. Swaiman's Pediatric Neurology. Swaiman's Pediatric Neurology
e234
e249
.
Carl Bradley Torrence, Claire DeCristofaro & Lydia Elliott. (2011) Empowering the primary care provider to optimally manage mild traumatic brain injury. Journal of the American Academy of Nurse Practitioners 23:12, pages 638-647.
Crossref
Crossref
Percival H. Pangilinan, Angela Giacoletti‐Argento, Renee Shellhaas, Edward A. Hurvitz & Joseph Edward Hornyak. (2010) Neuropharmacology in Pediatric Brain Injury: A Review. PM&R 2:12, pages 1127-1140.
Crossref
Crossref
Shirley Jett. (2010) Combat-Related Blast-Induced Neurotrauma: A Public Health Problem?. Nursing Forum 45:4, pages 237-245.
Crossref
Crossref
L. Keith Scott, Rebecca Green, Paul J. McCarthy & Steven A. Conrad. (2009) Agitation and/or aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Journal of Neurosurgery: Pediatrics 3:6, pages 484-487.
Crossref
Crossref